Respiratory disease

Showing   of 2 results

AlveoGene logo for thumbnail

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.

Key Mechanisms of Airway Relaxation in Asthma Revealed in New Study

Novel role for nitric oxide in treatment of asthma and other obstructive airway diseases detailed by team at University Hospitals and Case Western Reserve University.

Results are loading...